These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 16357166)
1. Context-dependent hormone-refractory progression revealed through characterization of a novel murine prostate cancer cell line. Watson PA; Ellwood-Yen K; King JC; Wongvipat J; Lebeau MM; Sawyers CL Cancer Res; 2005 Dec; 65(24):11565-71. PubMed ID: 16357166 [TBL] [Abstract][Full Text] [Related]
2. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells. Tso CL; McBride WH; Sun J; Patel B; Tsui KH; Paik SH; Gitlitz B; Caliliw R; van Ophoven A; Wu L; deKernion J; Belldegrun A Cancer J; 2000; 6(4):220-33. PubMed ID: 11038142 [TBL] [Abstract][Full Text] [Related]
3. Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline. Hara T; Nakamura K; Araki H; Kusaka M; Yamaoka M Cancer Res; 2003 Sep; 63(17):5622-8. PubMed ID: 14500404 [TBL] [Abstract][Full Text] [Related]
4. NE-10 neuroendocrine cancer promotes the LNCaP xenograft growth in castrated mice. Jin RJ; Wang Y; Masumori N; Ishii K; Tsukamoto T; Shappell SB; Hayward SW; Kasper S; Matusik RJ Cancer Res; 2004 Aug; 64(15):5489-95. PubMed ID: 15289359 [TBL] [Abstract][Full Text] [Related]
5. Evolution of the androgen receptor pathway during progression of prostate cancer. Hendriksen PJ; Dits NF; Kokame K; Veldhoven A; van Weerden WM; Bangma CH; Trapman J; Jenster G Cancer Res; 2006 May; 66(10):5012-20. PubMed ID: 16707422 [TBL] [Abstract][Full Text] [Related]
6. Antisense Bcl-2 oligodeoxynucleotides inhibit progression to androgen-independence after castration in the Shionogi tumor model. Miyake H; Tolcher A; Gleave ME Cancer Res; 1999 Aug; 59(16):4030-4. PubMed ID: 10463603 [TBL] [Abstract][Full Text] [Related]
7. Development of an androgen-deprivation induced and androgen suppressed human prostate cancer cell line. Lee SO; Dutt SS; Nadiminty N; Pinder E; Liao H; Gao AC Prostate; 2007 Sep; 67(12):1293-300. PubMed ID: 17626246 [TBL] [Abstract][Full Text] [Related]
8. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer. Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594 [TBL] [Abstract][Full Text] [Related]
9. PC-1/PrLZ contributes to malignant progression in prostate cancer. Zhang H; Wang J; Pang B; Liang RX; Li S; Huang PT; Wang R; Chung LW; Zhau HE; Huang C; Zhou JG Cancer Res; 2007 Sep; 67(18):8906-13. PubMed ID: 17875733 [TBL] [Abstract][Full Text] [Related]
10. Expression and role of Foxa proteins in prostate cancer. Mirosevich J; Gao N; Gupta A; Shappell SB; Jove R; Matusik RJ Prostate; 2006 Jul; 66(10):1013-28. PubMed ID: 16001449 [TBL] [Abstract][Full Text] [Related]
12. Molecular regulation of androgen action in prostate cancer. Dehm SM; Tindall DJ J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832 [TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
14. Myc confers androgen-independent prostate cancer cell growth. Bernard D; Pourtier-Manzanedo A; Gil J; Beach DH J Clin Invest; 2003 Dec; 112(11):1724-31. PubMed ID: 14660748 [TBL] [Abstract][Full Text] [Related]
15. Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis. Wang XD; Wang BE; Soriano R; Zha J; Zhang Z; Modrusan Z; Cunha GR; Gao WQ Differentiation; 2007 Mar; 75(3):219-34. PubMed ID: 17288544 [TBL] [Abstract][Full Text] [Related]
16. Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth. Takayama K; Tsutsumi S; Suzuki T; Horie-Inoue K; Ikeda K; Kaneshiro K; Fujimura T; Kumagai J; Urano T; Sakaki Y; Shirahige K; Sasano H; Takahashi S; Kitamura T; Ouchi Y; Aburatani H; Inoue S Cancer Res; 2009 Jan; 69(1):137-42. PubMed ID: 19117996 [TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of molecular targets on clonal cancer lines derived from a novel hormone-refractory prostate cancer tumor system. Freedland SJ; Pantuck AJ; Paik SH; Zisman A; Graeber TG; Eisenberg D; McBride WH; Nguyen D; Tso CL; Belldegrun AS Prostate; 2003 Jun; 55(4):299-307. PubMed ID: 12712409 [TBL] [Abstract][Full Text] [Related]